-
My Account
In App
My Account
| Particulars | This Scheme | Category |
|---|---|---|
| No. of Stocks | 20 | 43.41 |
| Top 5 Stock Weight | 58.34% | 32.46% |
| Top 10 Stock Weight | 78.97% | 49.59% |
| Top 3 Sector Weight | % | 43.5% |
| Particulars | This Scheme | Category |
|---|---|---|
| Average mcap (Cr) | 40556.82 | 72450.57 |
| Holdings in large cap stocks | 53.23% | 37.14% |
| Holdings in mid cap stocks | 19.75% | 14.47% |
| Holdings in small cap stocks | 2.61% | 13.09% |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 201.4 | 22.18% | 0.00% | 25.51% (Apr 2025) | 21.61% (Sep 2025) | 1.19 L | -0.25 k |
| # Divis Laboratories Ltd. | Pharmaceuticals | 96.8 | 10.66% | 0.00% | 11.01% (May 2025) | 9.3% (Sep 2025) | 14.36 k | -27.00 |
| # Cipla Ltd. | Pharmaceuticals | 95.5 | 10.51% | 0.00% | 11.42% (Aug 2025) | 10.2% (Dec 2024) | 63.59 k | -0.13 k |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 82.5 | 9.08% | 0.00% | 10.28% (Dec 2024) | 9.23% (Mar 2025) | 68.88 k | -0.14 k |
| # Lupin Ltd. | Pharmaceuticals | 53.7 | 5.91% | 0.00% | 6.89% (Dec 2024) | 5.7% (Jul 2025) | 27.35 k | -56.00 |
| # Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 42.1 | 4.64% | 0.00% | 4.85% (Sep 2025) | 3.73% (Oct 2024) | 11.83 k | -21.00 |
| # Laurus Labs Ltd. | Pharmaceuticals | 41.9 | 4.61% | 0.00% | 4.29% (Aug 2025) | 2.44% (Oct 2024) | 43.92 k | -89.00 |
| # Aurobindo Pharma Ltd. | Pharmaceuticals | 36 | 3.97% | 0.00% | 4.92% (Oct 2024) | 3.67% (Aug 2025) | 31.62 k | -63.00 |
| # Alkem Laboratories Ltd. | Pharmaceuticals | 35.1 | 3.86% | 0.00% | 3.93% (Sep 2025) | 3.31% (Jul 2025) | 6.37 k | -9.00 |
| # Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 32.2 | 3.55% | 0.00% | 3.93% (Jul 2025) | 2.69% (Apr 2025) | 17.03 k | -33.00 |
| Stock Invested in |
Sector |
Sector Total |
Value(Mn) |
% of Total Holdings |
1M Change |
1Y Highest Holding |
1Y Lowest Holding |
Quantity |
1M Change in Qty |
M-Cap |
GroupName |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 100 | 201.4 | 22.18% | 0.00% | 25.51% (Apr 2025) | 21.61% (Sep 2025) | 1.19 L | -0.25 k | Large Cap | 53.23 |
| # Divis Laboratories Ltd. | Pharmaceuticals | 100 | 96.8 | 10.66% | 0.00% | 11.01% (May 2025) | 9.3% (Sep 2025) | 14.36 k | -27.00 | Large Cap | 53.23 |
| # Cipla Ltd. | Pharmaceuticals | 100 | 95.5 | 10.51% | 0.00% | 11.42% (Aug 2025) | 10.2% (Dec 2024) | 63.59 k | -0.13 k | Large Cap | 53.23 |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 100 | 82.5 | 9.08% | 0.00% | 10.28% (Dec 2024) | 9.23% (Mar 2025) | 68.88 k | -0.14 k | Other | 24.41 |
| # Lupin Ltd. | Pharmaceuticals | 100 | 53.7 | 5.91% | 0.00% | 6.89% (Dec 2024) | 5.7% (Jul 2025) | 27.35 k | -56.00 | Large Cap | 53.23 |
| # Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 100 | 42.1 | 4.64% | 0.00% | 4.85% (Sep 2025) | 3.73% (Oct 2024) | 11.83 k | -21.00 | Mid Cap | 19.75 |
| # Laurus Labs Ltd. | Pharmaceuticals | 100 | 41.9 | 4.61% | 0.00% | 4.29% (Aug 2025) | 2.44% (Oct 2024) | 43.92 k | -89.00 | Other | 24.41 |
| # Aurobindo Pharma Ltd. | Pharmaceuticals | 100 | 36 | 3.97% | 0.00% | 4.92% (Oct 2024) | 3.67% (Aug 2025) | 31.62 k | -63.00 | Large Cap | 53.23 |
| # Alkem Laboratories Ltd. | Pharmaceuticals | 100 | 35.1 | 3.86% | 0.00% | 3.93% (Sep 2025) | 3.31% (Jul 2025) | 6.37 k | -9.00 | Mid Cap | 19.75 |
| # Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 100 | 32.2 | 3.55% | 0.00% | 3.93% (Jul 2025) | 2.69% (Apr 2025) | 17.03 k | -33.00 | Mid Cap | 19.75 |
| # Mankind Pharma Ltd. | Pharmaceuticals | 100 | 30.5 | 3.36% | 0.00% | 3.65% (May 2025) | 3.11% (Nov 2024) | 12.78 k | -25.00 | Other | 24.41 |
| # Zydus Lifesciences Ltd. | Pharmaceuticals | 100 | 27.5 | 3.03% | 0.00% | 3.22% (Jan 2025) | 2.87% (Apr 2025) | 28.24 k | -56.00 | Mid Cap | 19.75 |
| # Biocon Ltd. | Pharmaceuticals | 100 | 25.3 | 2.78% | 0.00% | 2.87% (Jul 2025) | 1.79% (Oct 2024) | 67.91 k | -0.14 k | Mid Cap | 19.75 |
| # Ipca Laboratories Ltd. | Pharmaceuticals | 100 | 20 | 2.20% | 0.00% | 2.79% (Dec 2024) | 2.39% (Sep 2025) | 15.71 k | -33.00 | Other | 24.41 |
| # Gland Pharma Ltd. | Pharmaceuticals | 100 | 17.4 | 1.91% | 0.00% | 2.04% (Sep 2025) | 1.44% (Apr 2025) | 9.00 k | -17.00 | Other | 24.41 |
| # Abbott India Ltd. | Pharmaceuticals | 100 | 17.1 | 1.89% | 0.00% | 2.35% (Jun 2025) | 1.8% (Jan 2025) | 591.00 | 1.00 | Mid Cap | 19.75 |
| # J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 100 | 15.5 | 1.71% | 0.00% | 1.79% (Sep 2025) | 1.49% (Apr 2025) | 9.21 k | -16.00 | Other | 24.41 |
| # Piramal Pharma Ltd. | Pharmaceuticals | 100 | 14 | 1.54% | 0.00% | 1.52% (Sep 2025) | 0% (Oct 2024) | 69.87 k | -0.15 k | Other | 24.41 |
| # Wockhardt Ltd. | Pharmaceuticals | 100 | 12 | 1.32% | 0.00% | 1.61% (Sep 2025) | 0% (Oct 2024) | 9.34 k | -18.00 | Small Cap | 2.61 |
| # Ajanta Pharma Limited | Pharmaceuticals | 100 | 11.7 | 1.29% | 0.00% | 1.64% (Nov 2024) | 1.3% (Sep 2025) | 4.76 k | -10.00 | Small Cap | 2.61 |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| No new entrants in the portfolio in the last month. | ||||||||
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| No complete exits in the portfolio in the last month. | ||||||||
| Stock | Oct 2025 | Sep 2025 | Aug 2025 | Jul 2025 | Jun 2025 | May 2025 | Apr 2025 | Mar 2025 | Feb 2025 | Jan 2025 | Dec 2024 | Nov 2024 | Oct 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 22.18% | 21.61% | 21.97% | 22.49% | 22.86% | 23.72% | 25.51% | 24.74% | 24.66% | 24.96% | 24.72% | 24.77% | 25.18% |
| Cipla Ltd. | 10.51% | 10.88% | 11.42% | 10.69% | 10.71% | 10.81% | 11.26% | 10.73% | 11.09% | 10.78% | 10.20% | 10.86% | 10.76% |
| Divis Laboratories Ltd. | 10.66% | 9.30% | 9.95% | 10.24% | 10.94% | 11.01% | 9.98% | 9.70% | 9.98% | 9.39% | 9.40% | 10.10% | 9.43% |
| Dr. Reddys Laboratories Ltd. | 9.08% | 9.59% | 9.80% | 9.45% | 9.88% | 10.01% | 9.33% | 9.23% | 9.76% | 9.84% | 10.28% | 9.45% | 9.80% |
| Lupin Ltd. | 5.91% | 5.95% | 5.85% | 5.70% | 5.93% | 6.20% | 6.54% | 6.48% | 6.59% | 6.65% | 6.89% | 6.37% | 6.65% |
| Torrent Pharmaceuticals Ltd. | 4.64% | 4.85% | 4.76% | 4.78% | 4.51% | 4.35% | 4.49% | 4.46% | 3.97% | 4.07% | 3.83% | 3.95% | 3.73% |
| Aurobindo Pharma Ltd. | 3.97% | 3.90% | 3.67% | 3.90% | 4.01% | 4.21% | 4.44% | 4.29% | 4.24% | 4.34% | 4.53% | 4.55% | 4.92% |
| Alkem Laboratories Ltd. | 3.86% | 3.93% | 3.64% | 3.31% | 3.36% | 3.55% | 3.51% | 3.43% | 3.53% | 3.56% | 3.63% | 3.80% | 3.81% |
| Mankind Pharma Ltd. | 3.36% | 3.54% | 3.57% | 3.54% | 3.31% | 3.65% | 3.59% | 3.62% | 3.41% | 3.35% | 3.63% | 3.11% | 3.17% |
| Laurus Labs Ltd. | 4.61% | 4.21% | 4.29% | 4.18% | 3.59% | 3.13% | 3.05% | 3.18% | 2.97% | 3.05% | 2.88% | 2.87% | 2.44% |
| Glenmark Pharmaceuticals Ltd. | 3.55% | 3.78% | 3.70% | 3.93% | 3.34% | 2.88% | 2.69% | 3.07% | 2.76% | 2.90% | 2.94% | 2.96% | 3.22% |
| Zydus Lifesciences Ltd. | 3.03% | 3.16% | 3.13% | 2.96% | 3.13% | 3.05% | 2.87% | 2.93% | 3.14% | 3.22% | 2.95% | 3.11% | 3.16% |
| Ipca Laboratories Ltd. | 2.20% | 2.39% | 2.46% | 2.50% | 2.44% | 2.60% | 2.51% | 2.76% | 2.64% | 2.60% | 2.79% | 2.70% | 2.72% |
| Biocon Ltd. | 2.78% | 2.63% | 2.67% | 2.87% | 2.70% | 1.98% | 1.87% | 2.04% | 1.95% | 2.16% | 1.99% | 2.11% | 1.79% |
| Abbott India Ltd. | 1.89% | 1.96% | 2.09% | 2.19% | 2.35% | 2.08% | 2.03% | 2.12% | 2.26% | 1.80% | 1.87% | 1.86% | 1.90% |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.67% |
| Net Receivables | Net Receivables | -0.65% |
Why Chase Market Highs with Risk When Fixed Returns are Right Here? 10.55% MEGHALAYA ENERGY CORPORATION LIMITED 2033 ✔️ Coupon: 10.55% ✔️ Rating: Acuite A-(CE) Stable, BRICKWORK A-(CE) Stable ✔️ Tenor: 7y 4m (Maturity: 03/Apr/2033)** Secured Bond | PSU Bond | High Return Bond | Listed Invest in a PSU-backed secured bond delivering a high fixed return, the smarter way to stay stable and grow money stronger. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJPb1pnPT0=/1055-meghalaya-energy-corporation-limited-2033?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more
Posted by : The Fixed Income
Repost this message
Why Chase Market Highs with Risk When Fixed Returns are Right Here? 10.55% MEGHALAYA ENERGY CORPORATION LIMITED 2033 ✔️ Coupon: 10.55% ✔️ Rating: Acuite A-(CE) Stable, BRICKWORK A-(CE) Stable ✔️ Tenor: 7y 4m (Maturity: 03/Apr/2033)** Secured Bond | PSU Bond | High Return Bond | Listed Invest in a PSU-backed secured bond delivering a high fixed return, the smarter way to stay stable and grow money stronger. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJPb1pnPT0=/1055-meghalaya-energy-corporation-limited-2033?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
need your suggestion for sbi psu fund direct growth stay or switch View more
Posted by : shravanashok
Dividend last declared by SBI Long Term Equity Fund - regular Plan -IDCW was in the year 2022. Is there any specific reason given by fund managers for non declaration of dividend. Please let me know. View more
Posted by : ravisistla
Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV. View more
Posted by : sunny85deol
